BACKGROUND: Clinically ascertained reports suggest that boys and girls with attention deficit hyperactivity disorder (ADHD) may differ from each other in their vulnerability to substance use problems. METHOD: A total of 1545 Finnish adolescents were assessed for DSM-IV-based ADHD symptoms by their parents and classroom teachers using standardized rating scales at age 11-12 years. At age 14, substance use disorders and psychiatric co-morbidity were assessed with the Semi-Structured Assessment for the Genetics of Alcoholism, providing DSM-III-R/DSM-IV diagnoses for Axis I disorders. At age 17.5, substance use was assessed by multi-item questionnaire. RESULTS: Although baseline ADHD symptoms were less common among females, they were more predictive of adverse substance use outcomes once conduct disorder and previous substance use were controlled for. Only in females were baseline ADHD symptoms significant predictors of alcohol abuse and dependence and illicit drug use at age 14. At the age of 17.5, parents' reports of inattentiveness and hyperactivity were significant predictors for frequent alcohol use in both sexes, but they were more predictive of frequent alcohol and illicit drug use in girls. Impulsivity in teachers' ratings predicted frequent alcohol use and illicit drug use in boys. Parental reports of inattentiveness in their 11-/12-year-old daughters were a consistent predictor for illicit drug use across adolescence. CONCLUSIONS: Inattentiveness and hyperactivity may be more predictive of alcohol use disorders and maladaptive patterns of alcohol and illicit drug use among girls than boys. The importance of these behavioural symptoms should be assessed further in the community, as they could jeopardize adolescents' successful transitioning into adult roles.
BACKGROUND: Clinically ascertained reports suggest that boys and girls with attention deficit hyperactivity disorder (ADHD) may differ from each other in their vulnerability to substance use problems. METHOD: A total of 1545 Finnish adolescents were assessed for DSM-IV-based ADHD symptoms by their parents and classroom teachers using standardized rating scales at age 11-12 years. At age 14, substance use disorders and psychiatric co-morbidity were assessed with the Semi-Structured Assessment for the Genetics of Alcoholism, providing DSM-III-R/DSM-IV diagnoses for Axis I disorders. At age 17.5, substance use was assessed by multi-item questionnaire. RESULTS: Although baseline ADHD symptoms were less common among females, they were more predictive of adverse substance use outcomes once conduct disorder and previous substance use were controlled for. Only in females were baseline ADHD symptoms significant predictors of alcohol abuse and dependence and illicit drug use at age 14. At the age of 17.5, parents' reports of inattentiveness and hyperactivity were significant predictors for frequent alcohol use in both sexes, but they were more predictive of frequent alcohol and illicit drug use in girls. Impulsivity in teachers' ratings predicted frequent alcohol use and illicit drug use in boys. Parental reports of inattentiveness in their 11-/12-year-old daughters were a consistent predictor for illicit drug use across adolescence. CONCLUSIONS: Inattentiveness and hyperactivity may be more predictive of alcohol use disorders and maladaptive patterns of alcohol and illicit drug use among girls than boys. The importance of these behavioural symptoms should be assessed further in the community, as they could jeopardize adolescents' successful transitioning into adult roles.
Authors: Andrea Prince van Leeuwen; Hanneke E Creemers; Frank C Verhulst; Johan Ormel; Anja C Huizink Journal: J Stud Alcohol Drugs Date: 2011-01 Impact factor: 2.582
Authors: Ronald C Kessler; Jennifer Greif Green; Lenard A Adler; Russell A Barkley; Somnath Chatterji; Stephen V Faraone; Matthew Finkelman; Laurence L Greenhill; Michael J Gruber; Mark Jewell; Leo J Russo; Nancy A Sampson; David L Van Brunt Journal: Arch Gen Psychiatry Date: 2010-11
Authors: Joseph Biederman; Eric Mick; Stephen V Faraone; Ellen Braaten; Alysa Doyle; Thomas Spencer; Timothy E Wilens; Elizabeth Frazier; Mary Ann Johnson Journal: Am J Psychiatry Date: 2002-01 Impact factor: 18.112
Authors: Irene J Elkins; Gretchen R B Saunders; Stephen M Malone; Margaret A Keyes; Matt McGue; William G Iacono Journal: Drug Alcohol Depend Date: 2017-12-27 Impact factor: 4.492
Authors: Leslie A Hulvershorn; Jennifer King; Patrick O Monahan; Holly C Wilcox; Philip B Mitchell; Janice M Fullerton; Howard J Edenberg; Gloria M P Roberts; Masoud Kamali; Anne L Glowinski; Neera Ghaziuddin; Melvin McInnis; Priya A Iyer-Eimerbrink; John I Nurnberger Journal: Compr Psychiatry Date: 2017-07-27 Impact factor: 3.735
Authors: Brooke S G Molina; Christine A P Walther; JeeWon Cheong; Sarah L Pedersen; Elizabeth M Gnagy; William E Pelham Journal: Exp Clin Psychopharmacol Date: 2014-03-10 Impact factor: 3.157
Authors: Irene J Elkins; Gretchen R B Saunders; Stephen M Malone; Sylia Wilson; Matt McGue; William G Iacono Journal: J Child Psychol Psychiatry Date: 2018-10 Impact factor: 8.982
Authors: Sarah H Stephens; Sarah M Hartz; Nicole R Hoft; Nancy L Saccone; Robin C Corley; John K Hewitt; Christian J Hopfer; Naomi Breslau; Hilary Coon; Xiangning Chen; Francesca Ducci; Nicole Dueker; Nora Franceschini; Josef Frank; Younghun Han; Nadia N Hansel; Chenhui Jiang; Tellervo Korhonen; Penelope A Lind; Jason Liu; Leo-Pekka Lyytikäinen; Martha Michel; John R Shaffer; Susan E Short; Juzhong Sun; Alexander Teumer; John R Thompson; Nicole Vogelzangs; Jacqueline M Vink; Angela Wenzlaff; William Wheeler; Bao-Zhu Yang; Steven H Aggen; Anthony J Balmforth; Sebastian E Baumeister; Terri H Beaty; Daniel J Benjamin; Andrew W Bergen; Ulla Broms; David Cesarini; Nilanjan Chatterjee; Jingchun Chen; Yu-Ching Cheng; Sven Cichon; David Couper; Francesco Cucca; Danielle Dick; Tatiana Foroud; Helena Furberg; Ina Giegling; Nathan A Gillespie; Fangyi Gu; Alistair S Hall; Jenni Hällfors; Shizhong Han; Annette M Hartmann; Kauko Heikkilä; Ian B Hickie; Jouke Jan Hottenga; Pekka Jousilahti; Marika Kaakinen; Mika Kähönen; Philipp D Koellinger; Stephen Kittner; Bettina Konte; Maria-Teresa Landi; Tiina Laatikainen; Mark Leppert; Steven M Levy; Rasika A Mathias; Daniel W McNeil; Sarah E Medland; Grant W Montgomery; Tanda Murray; Matthias Nauck; Kari E North; Peter D Paré; Michele Pergadia; Ingo Ruczinski; Veikko Salomaa; Jorma Viikari; Gonneke Willemsen; Kathleen C Barnes; Eric Boerwinkle; Dorret I Boomsma; Neil Caporaso; Howard J Edenberg; Clyde Francks; Joel Gelernter; Hans Jörgen Grabe; Hyman Hops; Marjo-Riitta Jarvelin; Magnus Johannesson; Kenneth S Kendler; Terho Lehtimäki; Patrik K E Magnusson; Mary L Marazita; Jonathan Marchini; Braxton D Mitchell; Markus M Nöthen; Brenda W Penninx; Olli Raitakari; Marcella Rietschel; Dan Rujescu; Nilesh J Samani; Ann G Schwartz; Sanjay Shete; Margaret Spitz; Gary E Swan; Henry Völzke; Juha Veijola; Qingyi Wei; Chris Amos; Dale S Cannon; Richard Grucza; Dorothy Hatsukami; Andrew Heath; Eric O Johnson; Jaakko Kaprio; Pamela Madden; Nicholas G Martin; Victoria L Stevens; Robert B Weiss; Peter Kraft; Laura J Bierut; Marissa A Ehringer Journal: Genet Epidemiol Date: 2013-11-01 Impact factor: 2.135
Authors: A Loukola; J Wedenoja; K Keskitalo-Vuokko; U Broms; T Korhonen; S Ripatti; A-P Sarin; J Pitkäniemi; L He; A Häppölä; K Heikkilä; Y-L Chou; M L Pergadia; A C Heath; G W Montgomery; N G Martin; P A F Madden; J Kaprio Journal: Mol Psychiatry Date: 2013-06-11 Impact factor: 15.992